0001825367-22-000001.txt : 20220211
0001825367-22-000001.hdr.sgml : 20220211
20220211160354
ACCESSION NUMBER: 0001825367-22-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220211
DATE AS OF CHANGE: 20220211
EFFECTIVENESS DATE: 20220211
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ventus Therapeutics U.S., Inc.
CENTRAL INDEX KEY: 0001794785
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 834463726
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-433406
FILM NUMBER: 22620658
BUSINESS ADDRESS:
STREET 1: 100 BEAVER STREET, SUITE 202
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 415-260-7371
MAIL ADDRESS:
STREET 1: 100 BEAVER STREET, SUITE 202
CITY: WALTHAM
STATE: MA
ZIP: 02453
D
1
primary_doc.xml
X0708
D
LIVE
0001794785
Ventus Therapeutics U.S., Inc.
100 BEAVER STREET, SUITE 202
WALTHAM
MA
MASSACHUSETTS
02453
514-397-9517
DELAWARE
None
None
Corporation
true
2019
Marcelo
Bigal
c/o Ventus Therapeutics U.S., Inc.
100 Beaver Street, Suite 202
Walthum
MA
MASSACHUSETTS
02453
Executive Officer
Director
Jerel
Davis
c/o Ventus Therapeutics U.S., Inc.
100 Beaver Street, Suite 202
Walthum
MA
MASSACHUSETTS
02453
Director
Brendan
Bulik-Sullivan
c/o Ventus Therapeutics U.S., Inc.
100 Beaver Street, Suite 202
Walthum
MA
MASSACHUSETTS
02453
Director
Daniel
Koerwer
c/o Ventus Therapeutics U.S., Inc.
100 Beaver Street, Suite 202
Walthum
MA
MASSACHUSETTS
02453
Executive Officer
Zachary
McNealy
c/o Ventus Therapeutics U.S., Inc.
100 Beaver Street, Suite 202
Walthum
MA
MASSACHUSETTS
02453
Executive Officer
Josh
Resnick
c/o Ventus Therapeutics U.S., Inc.
100 Beaver Street, Suite 202
Walthum
MA
MASSACHUSETTS
02453
Director
Steven
James
c/o Ventus Therapeutics U.S., Inc.
100 Beaver Street, Suite 202
Walthum
MA
MASSACHUSETTS
02453
Director
Michael
Crackower
c/o Ventus Therapeutics U.S., Inc.
100 Beaver Street, Suite 202
Waltham
MA
MASSACHUSETTS
02453
Executive Officer
Jane
Pritchett Henderson
c/o Ventus Therapeutics U.S., Inc.
100 Beaver Street, Suite 202
Walthum
MA
MASSACHUSETTS
02453
Director
Dolca
Thomas
c/o Ventus Therapeutics U.S., Inc.
100 Beaver Street, Suite 202
Walthum
MA
MASSACHUSETTS
02453
Director
Markus
Warmuth
c/o Ventus Therapeutics U.S., Inc.
100 Beaver Street, Suite 202
c/o Ventus Therapeutics U.S.,
MA
MASSACHUSETTS
02453
Director
John
Cassidy
c/o Ventus Therapeutics U.S., Inc.
100 Beaver Street, Suite 202
Walthum
MA
MASSACHUSETTS
02453
Director
Biotechnology
Decline to Disclose
- 06b
false
2022-02-07
false
true
false
0
139999982
70000006
69999976
false
13
0
0
0
false
Ventus Therapeutics U.S., Inc.
/s/ Zachary McNealy
Zachary McNealy
Chief Financial Officer
2022-02-09